A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Single Dose, Efficacy and Safety Outpatient Study of Staccato Prochlorperazine for Inhalation in Patients With Migraine Headache

Trial Profile

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Single Dose, Efficacy and Safety Outpatient Study of Staccato Prochlorperazine for Inhalation in Patients With Migraine Headache

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Jun 2007

At a glance

  • Drugs Prochlorperazine (Primary)
  • Indications Migraine
  • Focus Therapeutic Use
  • Sponsors Alexza Pharmaceuticals
  • Most Recent Events

    • 07 Jun 2007 Results were reported at AHS 2007.
    • 07 Jun 2007 Status change from in progress to completed.
    • 27 Mar 2007 Interim results have been reported.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top